Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Appendicitis | 12 | 2024 | 674 | 5.990 |
Why?
|
Delayed Diagnosis | 13 | 2024 | 462 | 5.390 |
Why?
|
Emergency Service, Hospital | 65 | 2024 | 7798 | 5.330 |
Why?
|
Anaphylaxis | 17 | 2023 | 755 | 3.780 |
Why?
|
Diabetic Ketoacidosis | 5 | 2024 | 253 | 3.170 |
Why?
|
Hospitals, Pediatric | 15 | 2024 | 1854 | 2.580 |
Why?
|
Emergency Medical Services | 9 | 2022 | 1915 | 2.270 |
Why?
|
Child | 93 | 2024 | 79782 | 1.720 |
Why?
|
Community-Acquired Infections | 2 | 2024 | 459 | 1.350 |
Why?
|
Meningitis, Bacterial | 3 | 2024 | 221 | 1.300 |
Why?
|
Sepsis | 6 | 2023 | 2579 | 1.280 |
Why?
|
Fever | 8 | 2024 | 1617 | 1.170 |
Why?
|
Hospitalization | 20 | 2024 | 10634 | 1.090 |
Why?
|
Gastroenteritis | 2 | 2020 | 236 | 1.080 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 25924 | 0.960 |
Why?
|
Child, Preschool | 39 | 2024 | 42045 | 0.940 |
Why?
|
Epinephrine | 9 | 2023 | 790 | 0.930 |
Why?
|
Retrospective Studies | 52 | 2024 | 79984 | 0.900 |
Why?
|
Pneumonia | 3 | 2024 | 2127 | 0.860 |
Why?
|
Infant | 33 | 2024 | 36045 | 0.850 |
Why?
|
Vital Signs | 1 | 2024 | 144 | 0.850 |
Why?
|
Pregnancy, Ectopic | 1 | 2024 | 141 | 0.830 |
Why?
|
Emergency Treatment | 3 | 2022 | 496 | 0.810 |
Why?
|
United States | 40 | 2024 | 71902 | 0.810 |
Why?
|
Amoxicillin | 1 | 2023 | 180 | 0.810 |
Why?
|
Abdominal Abscess | 1 | 2023 | 152 | 0.780 |
Why?
|
Urea Cycle Disorders, Inborn | 1 | 2021 | 32 | 0.780 |
Why?
|
Pediatrics | 8 | 2022 | 3586 | 0.750 |
Why?
|
Otitis Media | 1 | 2023 | 285 | 0.750 |
Why?
|
Appendectomy | 1 | 2024 | 430 | 0.710 |
Why?
|
Bacteremia | 3 | 2024 | 978 | 0.710 |
Why?
|
Hospital Units | 1 | 2021 | 142 | 0.700 |
Why?
|
Croup | 1 | 2020 | 23 | 0.700 |
Why?
|
Databases, Factual | 8 | 2024 | 7927 | 0.700 |
Why?
|
Humans | 118 | 2024 | 757566 | 0.670 |
Why?
|
Respiratory Tract Infections | 2 | 2024 | 1004 | 0.670 |
Why?
|
Metabolism, Inborn Errors | 1 | 2021 | 286 | 0.670 |
Why?
|
Spinal Puncture | 2 | 2020 | 281 | 0.660 |
Why?
|
Adolescent | 40 | 2024 | 87819 | 0.660 |
Why?
|
Spermatic Cord Torsion | 1 | 2019 | 72 | 0.640 |
Why?
|
Documentation | 2 | 2024 | 892 | 0.630 |
Why?
|
Ovariectomy | 1 | 2020 | 610 | 0.620 |
Why?
|
Ovarian Diseases | 1 | 2019 | 137 | 0.600 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2024 | 1014 | 0.600 |
Why?
|
Medically Uninsured | 2 | 2022 | 826 | 0.590 |
Why?
|
Inpatients | 3 | 2024 | 2536 | 0.580 |
Why?
|
Medicaid | 4 | 2024 | 2794 | 0.570 |
Why?
|
Encephalitis, Viral | 1 | 2017 | 58 | 0.570 |
Why?
|
Status Epilepticus | 3 | 2017 | 456 | 0.560 |
Why?
|
Bronchodilator Agents | 5 | 2023 | 505 | 0.530 |
Why?
|
Patient Transfer | 2 | 2020 | 774 | 0.520 |
Why?
|
Practice Guidelines as Topic | 4 | 2022 | 7366 | 0.510 |
Why?
|
Hospitals | 4 | 2024 | 3861 | 0.510 |
Why?
|
Biomedical Research | 2 | 2022 | 3415 | 0.500 |
Why?
|
Crowding | 2 | 2016 | 142 | 0.500 |
Why?
|
International Classification of Diseases | 1 | 2020 | 891 | 0.500 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 747 | 0.490 |
Why?
|
Abdominal Pain | 1 | 2021 | 1064 | 0.480 |
Why?
|
Asthma | 5 | 2023 | 6172 | 0.480 |
Why?
|
Emergencies | 1 | 2021 | 1209 | 0.480 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1292 | 0.470 |
Why?
|
Medicine | 1 | 2022 | 940 | 0.470 |
Why?
|
Bacterial Infections | 5 | 2024 | 1402 | 0.450 |
Why?
|
New York | 3 | 2023 | 873 | 0.450 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2018 | 327 | 0.440 |
Why?
|
Pandemics | 4 | 2023 | 8600 | 0.440 |
Why?
|
Patient Discharge | 8 | 2024 | 3428 | 0.430 |
Why?
|
Patient Readmission | 5 | 2024 | 3241 | 0.420 |
Why?
|
Length of Stay | 6 | 2024 | 6384 | 0.420 |
Why?
|
Evidence-Based Medicine | 2 | 2022 | 3670 | 0.400 |
Why?
|
Health Services Research | 1 | 2019 | 1811 | 0.400 |
Why?
|
Glucocorticoids | 3 | 2016 | 2144 | 0.390 |
Why?
|
Rural Population | 1 | 2022 | 2253 | 0.380 |
Why?
|
Data Collection | 2 | 2023 | 3319 | 0.380 |
Why?
|
Residence Characteristics | 2 | 2024 | 2058 | 0.370 |
Why?
|
Income | 1 | 2019 | 1867 | 0.360 |
Why?
|
Infant, Newborn | 15 | 2024 | 26176 | 0.360 |
Why?
|
Shiga-Toxigenic Escherichia coli | 2 | 2021 | 26 | 0.360 |
Why?
|
Hemolytic-Uremic Syndrome | 2 | 2021 | 106 | 0.350 |
Why?
|
Health Care Surveys | 3 | 2024 | 2425 | 0.340 |
Why?
|
Female | 48 | 2024 | 389943 | 0.330 |
Why?
|
Male | 44 | 2024 | 358180 | 0.330 |
Why?
|
Quality Improvement | 2 | 2022 | 3793 | 0.320 |
Why?
|
Internship and Residency | 4 | 2022 | 5854 | 0.320 |
Why?
|
Checklist | 1 | 2015 | 827 | 0.310 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1502 | 0.310 |
Why?
|
Maryland | 2 | 2019 | 275 | 0.310 |
Why?
|
Heart Arrest | 1 | 2018 | 1494 | 0.300 |
Why?
|
Mortality | 1 | 2019 | 2882 | 0.300 |
Why?
|
Hospital Charges | 2 | 2020 | 351 | 0.300 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5815 | 0.300 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2354 | 0.290 |
Why?
|
Acute Disease | 4 | 2023 | 7225 | 0.280 |
Why?
|
Labor, Induced | 1 | 2008 | 151 | 0.280 |
Why?
|
Electronic Health Records | 3 | 2024 | 4760 | 0.280 |
Why?
|
Referral and Consultation | 1 | 2020 | 3579 | 0.280 |
Why?
|
Leukocytosis | 3 | 2018 | 251 | 0.270 |
Why?
|
Escherichia coli Infections | 2 | 2021 | 523 | 0.270 |
Why?
|
Medicare | 2 | 2024 | 6724 | 0.260 |
Why?
|
Patient Admission | 1 | 2012 | 1364 | 0.240 |
Why?
|
Physicians | 2 | 2024 | 4577 | 0.240 |
Why?
|
Lyme Disease | 2 | 2023 | 630 | 0.240 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15781 | 0.230 |
Why?
|
Intensive Care Units | 3 | 2023 | 3732 | 0.230 |
Why?
|
Surge Capacity | 1 | 2024 | 48 | 0.230 |
Why?
|
Research Design | 1 | 2019 | 6152 | 0.220 |
Why?
|
Young Adult | 14 | 2024 | 58755 | 0.220 |
Why?
|
Drug Prescriptions | 3 | 2023 | 1666 | 0.220 |
Why?
|
Critical Illness | 1 | 2016 | 2705 | 0.220 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5382 | 0.220 |
Why?
|
Antipyretics | 1 | 2022 | 23 | 0.210 |
Why?
|
Erythroblasts | 1 | 2023 | 142 | 0.210 |
Why?
|
Biopharmaceutics | 1 | 2022 | 23 | 0.210 |
Why?
|
Social Problems | 1 | 2023 | 109 | 0.210 |
Why?
|
Health Personnel | 1 | 2016 | 3309 | 0.210 |
Why?
|
Radiography | 2 | 2024 | 6956 | 0.200 |
Why?
|
Mastitis | 1 | 2021 | 43 | 0.190 |
Why?
|
Chorioamnionitis | 1 | 2022 | 156 | 0.180 |
Why?
|
Case-Control Studies | 4 | 2023 | 22022 | 0.180 |
Why?
|
Economics, Hospital | 1 | 2023 | 209 | 0.180 |
Why?
|
Financing, Organized | 1 | 2022 | 204 | 0.180 |
Why?
|
Hospitals, Community | 1 | 2023 | 365 | 0.180 |
Why?
|
Sympathomimetics | 1 | 2020 | 56 | 0.180 |
Why?
|
Geography | 1 | 2022 | 658 | 0.180 |
Why?
|
Soft Tissue Infections | 1 | 2022 | 167 | 0.180 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 206 | 0.170 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2020 | 86 | 0.170 |
Why?
|
Cesarean Section | 1 | 2008 | 1383 | 0.170 |
Why?
|
Confidence Intervals | 2 | 2020 | 2922 | 0.170 |
Why?
|
Incidence | 4 | 2021 | 21217 | 0.170 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2022 | 370 | 0.170 |
Why?
|
Benzodiazepines | 2 | 2023 | 1130 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2020 | 5194 | 0.160 |
Why?
|
Logistic Models | 3 | 2024 | 13221 | 0.160 |
Why?
|
Predictive Value of Tests | 5 | 2023 | 15207 | 0.160 |
Why?
|
Area Under Curve | 1 | 2023 | 1632 | 0.160 |
Why?
|
Acetaminophen | 1 | 2022 | 552 | 0.160 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 791 | 0.160 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 694 | 0.160 |
Why?
|
Decision Making | 1 | 2012 | 3909 | 0.150 |
Why?
|
Seasons | 1 | 2024 | 1513 | 0.150 |
Why?
|
Tachycardia, Supraventricular | 1 | 2021 | 273 | 0.150 |
Why?
|
Prevalence | 4 | 2024 | 15640 | 0.150 |
Why?
|
Time Factors | 6 | 2020 | 39811 | 0.150 |
Why?
|
Self-Injurious Behavior | 1 | 2024 | 556 | 0.150 |
Why?
|
Health Resources | 1 | 2024 | 931 | 0.150 |
Why?
|
Laboratories | 1 | 2021 | 460 | 0.150 |
Why?
|
Algorithms | 1 | 2018 | 13952 | 0.150 |
Why?
|
Respiratory Rate | 1 | 2019 | 175 | 0.150 |
Why?
|
Rural Health Services | 1 | 2021 | 381 | 0.140 |
Why?
|
Meningitis, Viral | 1 | 2017 | 50 | 0.140 |
Why?
|
Stroke | 1 | 2019 | 9695 | 0.140 |
Why?
|
ROC Curve | 3 | 2020 | 3562 | 0.140 |
Why?
|
Gender Identity | 1 | 2023 | 757 | 0.140 |
Why?
|
Cohort Studies | 9 | 2023 | 41190 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 591 | 0.140 |
Why?
|
Shock, Septic | 1 | 2023 | 760 | 0.140 |
Why?
|
Leukocyte Count | 2 | 2018 | 1595 | 0.140 |
Why?
|
Odds Ratio | 3 | 2021 | 9624 | 0.140 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2016 | 62 | 0.130 |
Why?
|
Platelet Activating Factor | 1 | 2016 | 143 | 0.130 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 1406 | 0.130 |
Why?
|
Synovial Fluid | 1 | 2018 | 395 | 0.130 |
Why?
|
Histamine Antagonists | 1 | 2016 | 90 | 0.130 |
Why?
|
Body Temperature | 1 | 2019 | 777 | 0.130 |
Why?
|
Seizures | 2 | 2021 | 2919 | 0.130 |
Why?
|
Civil Defense | 1 | 2017 | 115 | 0.130 |
Why?
|
Airway Management | 1 | 2019 | 310 | 0.130 |
Why?
|
Perception | 1 | 2022 | 1194 | 0.120 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 651 | 0.120 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7399 | 0.120 |
Why?
|
Mass Casualty Incidents | 1 | 2017 | 179 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1199 | 0.120 |
Why?
|
Emergency Medicine | 2 | 2024 | 1194 | 0.120 |
Why?
|
Injections, Intramuscular | 3 | 2020 | 553 | 0.110 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2014 | 40 | 0.110 |
Why?
|
Patient Care Management | 1 | 2017 | 302 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2022 | 2212 | 0.110 |
Why?
|
Hospitals, General | 1 | 2018 | 795 | 0.110 |
Why?
|
Blast Injuries | 1 | 2017 | 322 | 0.110 |
Why?
|
Skin Diseases | 1 | 2022 | 1088 | 0.110 |
Why?
|
Boston | 3 | 2022 | 9298 | 0.110 |
Why?
|
Peanut Hypersensitivity | 1 | 2016 | 211 | 0.110 |
Why?
|
Schools | 1 | 2021 | 1482 | 0.100 |
Why?
|
Adult | 7 | 2024 | 219725 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1155 | 0.100 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20037 | 0.100 |
Why?
|
Age Distribution | 1 | 2018 | 2877 | 0.100 |
Why?
|
Risk Factors | 5 | 2024 | 73708 | 0.100 |
Why?
|
Mental Health | 2 | 2023 | 3228 | 0.100 |
Why?
|
Waiting Lists | 1 | 2016 | 761 | 0.100 |
Why?
|
Insurance Coverage | 1 | 2023 | 1919 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2021 | 1155 | 0.100 |
Why?
|
Students | 1 | 2021 | 1729 | 0.100 |
Why?
|
Hip Joint | 1 | 2018 | 1007 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2023 | 7796 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1113 | 0.090 |
Why?
|
Disaster Planning | 1 | 2017 | 557 | 0.090 |
Why?
|
Analgesics, Opioid | 3 | 2023 | 3762 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 933 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2022 | 2767 | 0.090 |
Why?
|
Multivariate Analysis | 1 | 2024 | 12047 | 0.090 |
Why?
|
Health Care Costs | 1 | 2024 | 3234 | 0.090 |
Why?
|
Hospitals, Urban | 1 | 2012 | 500 | 0.090 |
Why?
|
Urban Population | 1 | 2018 | 2023 | 0.090 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 984 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2548 | 0.080 |
Why?
|
Lipocalins | 1 | 2010 | 161 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6470 | 0.080 |
Why?
|
Acute-Phase Proteins | 1 | 2010 | 250 | 0.080 |
Why?
|
Drug Utilization | 1 | 2015 | 1187 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1397 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2690 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6070 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1821 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14637 | 0.070 |
Why?
|
Chronic Disease | 2 | 2023 | 9263 | 0.070 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2010 | 406 | 0.070 |
Why?
|
Delphi Technique | 2 | 2021 | 828 | 0.070 |
Why?
|
Consensus | 3 | 2021 | 3097 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2475 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3809 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4404 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8550 | 0.070 |
Why?
|
Glucose | 1 | 2017 | 4336 | 0.060 |
Why?
|
Neutrophils | 1 | 2018 | 3756 | 0.060 |
Why?
|
Risk Assessment | 3 | 2021 | 23816 | 0.060 |
Why?
|
Mental Disorders | 1 | 2024 | 6802 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3560 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12684 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18326 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14473 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2462 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2018 | 4307 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2023 | 396 | 0.050 |
Why?
|
Ibuprofen | 1 | 2022 | 229 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54092 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5325 | 0.040 |
Why?
|
Spain | 1 | 2021 | 488 | 0.040 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 117 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 750 | 0.040 |
Why?
|
Computers | 1 | 2021 | 596 | 0.040 |
Why?
|
Hospital Costs | 1 | 2024 | 949 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 281 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4492 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2018 | 234 | 0.040 |
Why?
|
North America | 1 | 2021 | 1273 | 0.040 |
Why?
|
Endemic Diseases | 1 | 2018 | 190 | 0.040 |
Why?
|
Bombs | 1 | 2017 | 73 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2021 | 776 | 0.030 |
Why?
|
Temperature | 1 | 2023 | 2217 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2109 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1703 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 931 | 0.030 |
Why?
|
Arthritis, Infectious | 1 | 2018 | 345 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 833 | 0.030 |
Why?
|
Cell Count | 1 | 2018 | 1834 | 0.030 |
Why?
|
Pregnancy | 2 | 2022 | 29712 | 0.030 |
Why?
|
Aged | 2 | 2023 | 167890 | 0.030 |
Why?
|
Diarrhea | 1 | 2020 | 1317 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1533 | 0.030 |
Why?
|
Signal Transduction | 1 | 2016 | 23335 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1458 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2023 | 2154 | 0.030 |
Why?
|
Research | 1 | 2021 | 1974 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2267 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2022 | 6292 | 0.030 |
Why?
|
Running | 1 | 2017 | 483 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20499 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4845 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2196 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2847 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3864 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5243 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36270 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8426 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10749 | 0.020 |
Why?
|
New York City | 1 | 2010 | 726 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6363 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10477 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1177 | 0.020 |
Why?
|
Clinical Competence | 1 | 2020 | 4760 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13463 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3565 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4110 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29488 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8946 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64242 | 0.010 |
Why?
|